Latest News

01.24.20

USRetina Announces RetinaOS To Help Practices Better Understand and Manage Business Efficiently

Source: USRetina

01.24.20

USRetina Announces Changes to Senior Management Team

Source: USRetina

01.24.20

Optimal Atropine Concentration for Two Year Myopia Control Affirmed

Source: Reuters

01.23.20

Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for DR and DME from Apexian Pharmaceuticals

Source: Ocuphire Pharma

01.23.20

The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial of Tepezza for Thyroid Eye Disease

Source: Horizon Therapeutics

01.23.20

Treat-and-Extend Approach With Ranibizumab Effective in AMD

Source: Reuters Health

01.22.20

Tangible Science Announces Timing for Tangible Boost Launch

Source: Tangible Science

01.22.20

Oertli Launches the ViPer Illuminated Scleral Indentor for Retinal Surgery

Source: Oertli Instrumente

01.22.20

Clearwave Launches New Patient Interface Solution

Source: Clearwave

01.22.20

Alexander van der Mey Named New CCO at Optimo Medical AG

Source: Optimo Medical

01.21.20

Covenant Surgical Partners Rebrands Company, Announces Partnership With Texas Eye Care Network

Source: Covenant Physician Partners

01.21.20

AOA Receives Department of Justice Approval to Expand Group Purchasing Activities for Its AOAExcel Members

Source: VisionMonday

01.21.20

Aerie Pharmaceuticals Announces FDA Approval of its Athlone, Ireland Facility for Production of Rocklatan

Source: Aerie Pharmaceuticals

01.20.20

FDA Accepting Less Data, More Surrogate Endpoints in Trials

Source: Medscape

01.20.20

Study Finds Fewer Than Half of US Clinical Trials Complied With New Regulations on Reporting Results

Source: FirstWord

01.17.20

The Vision Council Notes That U.S.-China Trade Agreement Will Result in Tariff Reductions on Certain Optical Products

Source: VisionMonday

View more stories